Trek Financial’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$346K Sell
2,210
-286
-11% -$42.9K 0.02% 384
2026
Q1
$381K Buy
2,496
+418
+20% +$64.1K 0.02% 336
2025
Q4
$286K Buy
+2,078
New +$272K 0.02% 373

Other funds holding NVS

Trek Financial's NVS Position: Q2 2026 in Review

Trek Financial reduced its Novartis (NVS) stake by 11% in Q2 2026, selling an estimated $42.9K and leaving 2,210 shares worth $346K. The position accounts for 0.02% of the portfolio, ranked #384.

Trek Financial first reported a position in NVS in Q4 2025 and has held it in 3 quarters since. The position peaked at $381K in Q1 2026. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Trek Financial held 2,210 shares of Novartis worth $346K as of Q2 2026.
  • Trek Financial sold 286 Novartis shares in Q2 2026, an estimated $42.9K.
  • Novartis made up 0.02% of Trek Financial's portfolio in Q2 2026, its #384 holding.
  • Trek Financial first reported a position in Novartis in Q4 2025 and has held it in 3 quarters since.
  • Trek Financial's Novartis position peaked at $381K in Q1 2026.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Trek Financial's 13F filing for Q2 2026, filed 13 Aug 2026.